Thrombosis and Haemostasis

LinksSchließen

Referenz

Massicotte P, Julian JA, Gent M. , et al; PROTEKT Study Group.
An open-label randomized controlled trial of low molecular weight heparin for the prevention of central venous line-related thrombotic complications in children: the PROTEKT trial.

Thromb Res 2003;
109 (2-3): 101-108

Bibliographische Angaben herunterladen

Aufrufen in: